Literature DB >> 11533497

Vascular complications after hemostatic puncture closure device (Angio-Seal) are not higher in overweight patients.

P Wong1, S Harding, D Walters, M L Hull, I K Jang.   

Abstract

BACKGROUND: Angio-Seal (Daig Corporation, Minnetonka, Minnesota) allows earlier discharge from the hospital after coronary angiography. Manual compression in overweight patients after percutaneous procedures is associated with a higher incidence of groin complications. The purpose of this study was to determine if a vascular closure device could be safely used without increasing the risk of vascular complications in overweight patients.
METHODS: A total of 198 patients who received the 6 French Angio-Seal device after diagnostic coronary angiography were divided into 3 groups. Group A included patients with a body mass index (BMI) of < or = 25, group B with BMI between 25 and 30, and group C with BMI > or = 30. Patients were followed for groin complications during their hospital stay.
RESULTS: Complication rates were comparable between the 3 groups. Groin complications occurred in 11% in group A, 5% in group B and 6% in group C.
CONCLUSION: After diagnostic cardiac catheterization, a vascular closure device such as Angio-Seal can be safely used in overweight patients.

Entities:  

Mesh:

Year:  2001        PMID: 11533497

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  2 in total

1.  Hemostatic closure device after carotid puncture for stent and coil placement in an intracranial aneurysm: technical note.

Authors:  Raphaël Blanc; Charbel Mounayer; Michel Piotin; Jean-Claude Sadik; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

Review 2.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.